Phillip E Spiess

49PUBLICATIONS
217CO-AUTHORS
Predictive and prognostic markersCancer diagnosisCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Gene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (49)

|Sep 15, 2026
Role of Second-Look Ureterorenoscopy After Endoscopic Treatment of Upper Tract Urothelial Carcinoma.

|Aug 19, 2026
Inguinal/pelvic lymph node involvement in penile squamous cell carcinoma by 18F-fluorodeoxyglucose PET/CT.

|Jul 27, 2026
Vaccine Therapy for the Management of Penile Cancer: Evidence, Opportunities and Challenges.

|Jul 15, 2026
Histological Subtypes of Bladder Cancer: Epidemiology, Molecular Biology, and Clinical Implications.

|Jun 02, 2026
Risk factors and causes of early death in germ cell tumors: a Global Society for Rare GU tumors study.

|May 25, 2026
Pembrolizumab plus high-dose IL-2 in advanced clear cell renal cell carcinoma: six-year survival outcomes and molecular signatures from a phase 2 trial.

Pageof 9

Frequent Collaborators

15 joint publications

Andrea Necchi

7 joint publications

Jad Chahoud

5 joint publications

Ashish M Kamat

5 joint publications

Filippo Pederzoli